insights_auto
Why is AZN up २.८५%?
Dive Deeperchevron_right
AZN:NYSE
AstraZeneca PLC (US)
US$ १६६.६८
arrow_upward
+२.८५%(+४.६२) 1D
US$ १६९.०२
arrow_upward
+१.४०% (+२.३४)bedtimeAfter hours
Closed: अक्टोबर १५, १६:००:०३ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AZN...
Open
US$ १६७.६९
High
US$ १६९.८१
Low
US$ १६६.४९
Mkt. cap
२.६२ खरब
Avg. vol.
२९.३४ लाख
Volume
४२.२८ लाख
Dividend
१.९३%
Quarterly dividend
US$ ०.८१
Ex-dividend date
२०२६ अगस्ट ६
P/E ratio
२४.९२
52-wk high
US$ २१२.७१
52-wk low
US$ ८०.४८
EPS
US$ ६.६९
Beta
०.३०
Shares outstanding
१.५५ अरब
No. of employees
९६ हजार
Open
US$ १६७.६९
High
US$ १६९.८१
Low
US$ १६६.४९
Mkt. cap
२.६२ खरब
Avg. vol.
२९.३४ लाख
Volume
४२.२८ लाख
Dividend
१.९३%
Quarterly dividend
US$ ०.८१
Ex-dividend date
२०२६ अगस्ट ६
P/E ratio
२४.९२
52-wk high
US$ २१२.७१
52-wk low
US$ ८०.४८
EPS
US$ ६.६९
Beta
०.३०
Shares outstanding
१.५५ अरब
No. of employees
९६ हजार
News stories
From web sources and news partners
Yahoo Finance
·
१ घण्टा पहिले
AstraZeneca (LSE:AZN) Enters AI Drug Discovery Partnership In MASH And Cardiomyopathies
Zacks
·
२ घण्टा पहिले
Can Gilead's Deal With VIR Boost Its Oncology Pipeline and Growth?
TradingKey
·
४ घण्टा पहिले
AstraZeneca PLC Stock (AZN) Moved Up by 3.55% on Oct 15: What Signal Does It Send?
Reuters
·
५ घण्टा पहिले
AstraZeneca strikes $40 million AI drug discovery deal with insitro
Profile
AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden; and Gaithersburg, Maryland, US.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Wikipedia
About AstraZeneca PLC (US)
CEOPascal Soriot
Employees९६.१ हजार
Founded१९९९ अप्रिल ६
Headquartersक्याम्ब्रिज, Cambridgeshire, संयुक्त अधिराज्य
Sector-
Websiteastrazeneca.com